The Potential of Pneumococcal Conjugate Vaccines to Reduce Antibiotic Resistance
Streptococcus pneumoniae is one of the most important bacterial pathogens in respiratory tract infections. Together with untypeable Haemophilus influenzae it is one of the two most common causes of acute otitis media (AOM). In addition, it is the most frequent cause of bacterial community acquired pneumonia, and one of the leading organisms causing sinusitis, sepsis, and meningitis.
KeywordsAcute Otitis Medium Conjugate Vaccine Pneumococcal Vaccine Young Sibling Pneumococcal Conjugate Vaccine
Unable to display preview. Download preview PDF.
- Block, S., Hedrick, J., and Harrison, C. (1999). Pneumococcal serotypes from acute otitis media in rural Kentucky [Abstract 1185]. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco, CA). American Society for Microbiology, Washington, DC.Google Scholar
- Dagan, R., Muallem, M., Melamed, R., Leroy, O., and Yagupsky, P. (1997). Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr. Infect. Dis. J. 16, 1060–1064.PubMedCrossRefGoogle Scholar
- Dagan, R., Zamir, O., Tirosh, N., Belmaker, I., Guy, L., Greenberg, D. et al. (2000c). Nasopharyngeal carriage of Streptococcus pneumoniae in toddlers vaccinated during infancy with an 11 valent pneumococcal vaccine conjugated to diphtheria and tetanus toxoids [Abstract 47]. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto, Canada). American Society for Microbiology, Washington, DC.Google Scholar
- Dagan, R., Givon-Lavi, N., Zamir, O., Sikuler-Cohen, M., Guy, L., Janco, J. et al. (2002). Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J. Infect. Dis. 185, 927–936.PubMedCrossRefGoogle Scholar
- Edwards, K.M., Wandling, G., Palmer, P., and Decker, M.D. (1999). Carriage of pneumococci among infants immunized with a 9-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age [Abstract 34]. 37th Annual Meeting of the Infectious Diseases Society of America (Philadelphia, PA). Infectious Diseases Society of America, Alexandria, VA.Google Scholar
- Joloba, M.L., Windau, A., Bajaksouzian, S., Appelbaum, P.C., Hausdorff, W.P., and Jacobs, M.R. (2001). Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin. Infect. Dis. 33, 1489–1494.PubMedCrossRefGoogle Scholar
- Kristinsson, K.G., Sigurdardottir, S.T., and Gudnason, T. (1997). Effect of vaccination with octavalent protein conjugated pneumococcal vaccines on pneumococcal carriage in infants [Abstract G-5]. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto, Ontario, Canada). American Society for Microbiology, Washington, DC.Google Scholar
- O’Brien, K., Bronsdon, M.A., Carlone, G., Facklam, R.R., Schwartz, B., Reid, R. et al. (2001). Effect of a seven valent pneumococcal conjugate vaccine on nasopharyngeal (NP) carriage among native American infants [Abstract 1463]. Pediatric Academic Societies Annual Meeting (Baltimore, MD.) Pediatric Research, Program Issue.Google Scholar
- Porat, N., Barkai, G., Jacobs, M.R., Trefler, R., and Dagan, R. (2004). Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J. Infect. Dis. 189, 385–392.PubMedCrossRefGoogle Scholar